researchdrivelogo.jpg
Global Antiviral Therapies Market Expected to Surpass to $66,016.5 Million and Exhibit a CAGR of 3.1% from 2020 to 2027 - Exclusive Report [Pages - 208] by Research Dive
April 12, 2021 09:15 ET | Research Dive
New York, USA , April 12, 2021 (GLOBE NEWSWIRE) -- Research Dive in its latest published report estimates that the global antiviral therapies market will generate $66,016.5 million and exhibit...
Graphical Research.jpg
Antiviral Drugs Market Size & Share | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
April 12, 2021 06:00 ET | Graphical Research
Pune, India, April 12, 2021 (GLOBE NEWSWIRE) -- The global antiviral drugs market size is anticipated to witness accelerated growth during the forecast period due to the growing focus toward...
VIR_logo_large.jpg
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
February 25, 2021 16:01 ET | Vir Biotechnology, Inc.
SAN FRANCISCO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended...
VIR_logo_large.jpg
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
February 17, 2021 07:04 ET | Vir Biotechnology, Inc.
– Companies applying their combined expertise in immunology and infectious diseases to accelerate the development of promising monoclonal antibody candidates for influenza – – Functional genomics...
logo-dark.png
Aegis Sciences Corporation Launches Combined Test for SARS-CoV-2 and Influenza A/B Virus
November 16, 2020 11:20 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
7 Hills Logo.png
7 Hills Pharma Announces First Healthy Volunteers Dosed in Landmark Phase 1 Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines
November 09, 2020 05:30 ET | 7 Hills Pharma
HOUSTON, Nov. 09, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
It’s Time To Look At UV-C Light Air Purification To Combat COVID-19 More Seriously
November 02, 2020 08:45 ET | Vystar Corp.
Worcester, MA and Palm Springs, CA, Nov. 02, 2020 (GLOBE NEWSWIRE) -- “It’s time to look more seriously at UV-C light air purification to help protect against airborne pathogens such as COVID-19,...
More than 50 PA Organizations, Businesses Encourage Flu Shots Harrisburg, PA, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Today, a group of more than 50 organizations and businesses listed below endorse the following statement: As seasons change, we make preparations...
VIR_logo_large.jpg
Vir Biotechnology Presents New Data on VIR-2482, the Company’s Investigational Monoclonal Antibody for the Prevention of Influenza A, at IDWeek 2020
October 21, 2020 08:00 ET | Vir Biotechnology, Inc.
– Preclinical data show VIR-2482 has broad neutralizing potential against all major strains of influenza A from the last 100 years – – Extended half-life observed in Phase 1 demonstrates potential...
RxAir Readying Rx3000 UV Light/HEPA Air Purifier for Large Scale Manufacturing
October 16, 2020 08:15 ET | Vystar Corp.
Rx3000® UV-C Light, HEPA filtration combination inactivates and traps 99.9% of airborne viruses, bacteria, mold, fungi and particulatesRX3000 is a “Made in the USA” FDA Cleared Class II medical device...